The Transformative Power of AI Technology in Pharmacovigilance
Tuesday, 1 October 2024, 07:03
Understanding AI Technology in Pharmacovigilance
AI technology has *emerged* as a vital solution addressing inconsistencies in adverse event reporting, a critical issue in pharmacovigilance. Eric Prugh, CPO of Authenticx, highlights how AI enhances data management processes while ensuring regulatory compliance.
The Impact on Clinical Trials and Development
In the context of clinical trials, AI plays a pivotal role in improving efficiencies during development and in contract sales & marketing. This not only streamlines processes but also ensures better reporting accuracy and faster drug approvals.
- Enhanced accuracy in reporting adverse events
- Improved efficiency in clinical development
- Strengthened compliance with regulatory news
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.